In comparison with the mice in the control group, the expression levels of VEGF, pVEGFR2, p‐PI3K, p‐AKT, p‐ERK1/2 and Ki‐67 in tumours obtained from apatinib‐treated mice were significantly downregulated (p < 0.05). The gene discussed is MAPK3; the disease is neoplasm.